For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Biotheranostics, Inc.

USPTO Granted Patents = 17

EPO Patents = 9

Trademarks = 8

Forward Citations = 111

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Mark G Erlander (15 out of 56 patents)

Xiao-Jun Ma (10 out of 10 patents)

Dennis Sgroi (9 out of 13 patents)

4. Yi Zhang (7 out of 41 patents)

5. Catherine A Schnabel (7 out of 7 patents)

6. Dennis C Sgroi (0 patent)

7. Brock Schroeder (0 patent)

8. Chin-Lee Wu (0 patent)

9. Edward Enright (0 patent)

17 patents: Sort by Forward Citations

1. 12595516 - NEUROENDOCRINE TUMORS (2026-04-07),

2. 12492432 - TUMOR GRADING AND CANCER PROGNOSIS (2025-12-09),

3. 12460265 - Post-treatment breast cancer prognosis (2025-11-04),

4. 12215390 - Integration of tumor characteristics with breast cancer index (2025-02-04),

5. 11549148 - Neuroendocrine tumors (2023-01-10),

6. 11530448 - Integration of tumor characteristics with breast cancer index (2022-12-20),

7. 11430544 - Identification of tumors and tissues (2022-08-30),

8. 11078538 - Post-treatment breast cancer prognosis (2021-08-03),

9. 11021754 - Tumor grading and cancer prognosis (2021-06-01),

10. 10538816 - Identification of tumors (2020-01-21),

11. 10329624 - Grading of breast cancer (2019-06-25),

12. 10253369 - Predicting likelihood of response to combination therapy (2019-04-09),

13. 9856533 - Predicting breast cancer treatment outcome (2018-01-02),

14. 9670553 - Determining tumor origin (2017-06-06),

15. 9447470 - Tumor grading and cancer prognosis (2016-09-20),

Biotheranostics, Inc. is a molecular diagnostics company specializing in the development and commercialization of innovative diagnostic tests for cancer treatment. They provide clinically validated molecular biomarker tests that help healthcare professionals make more personalized treatment decisions for cancer patients. Their tests are designed to provide insights into the underlying biology of tumors, allowing for targeted therapy and improved patient outcomes. With a focus on precision medicine, Biotheranostics aims to improve the standard of care and contribute to the advancement of cancer diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

17 Patents

#338 in San Diego, CA

#4,503 in California

#18,849 in US

#35,819 in the World

San Diego, CA, United States of America

Biotheranostics, Inc.

Forward Citations = 111

5 inventors:

Mark G Erlander (15 out of 56 patents)

Xiao-Jun Ma (10 out of 10 patents)

Dennis Sgroi (9 out of 13 patents)

4. Yi Zhang (7 out of 41 patents)

5. Catherine A Schnabel (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…